Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that while the over-the-counter market for minoxidil hair loss products is expanding, only 25% of these products report safety information, and none report adverse effects, highlighting a need for greater transparency and accuracy in their advertising.

Minoxidil can help grow hair and make hair follicles bigger, but it can also cause side effects.

This study evaluated the efficacy and safety of a 5% minoxidil topical foam without propylene glycol in men with androgenic alopecia.

This study found that topical application of 2% minoxidil solution was not effective in improving erectile dysfunction in the majority of participants.

Minoxidil helps hair grow, especially in people with mild hair loss.

This study suggests that the novel "After Minoxidil" spray improved styling ease and reduced greasiness in patients using topical minoxidil, which may enhance compliance and treatment efficacy.

This study found that 3% topical minoxidil decreased hair shedding and promoted hair growth in women with androgenetic alopecia.

This article reviews expert opinions on combining pharmacologic treatments like minoxidil with hair transplantation, reporting improved hair density and regrowth in patients with partially functioning follicles.

In this study, topical 2% minoxidil did not significantly improve hair density measures in men with male pattern baldness, although there was no deterioration, suggesting a potential prophylactic effect.

This study evaluated high-dose oral minoxidil treatment in 57 patients with androgenetic alopecia and found it improved hair density by 10-30% in most cases, but 24.6% experienced adverse effects like hypertrichosis and tachycardia, indicating further research is needed to optimize safety and efficacy.

This study concluded that oral and topical minoxidil have similar overall benefits in treating androgenetic alopecia, but topical minoxidil improved hair density more and had fewer adverse effects.

This study investigated adverse events from low-dose systemic minoxidil in an older population with hair loss and found that 19% experienced mainly facial and body hypertrichosis, managed with interventions like dose reduction and diuretics; no serious adverse events occurred.

In this study, both 5% and 10% topical minoxidil showed similar overall efficacy in treating male-pattern hair loss, though the 10% concentration resulted in greater improvement in frontal hair count but also more side effects.

This review discusses the efficacy of Minoxidil and finasteride for treating androgenetic alopecia and suggests that combined therapy may offer superior results and improved patient adherence despite potential side effects.

In this study, 67 patients developed contact dermatitis from using minoxidil for hair loss, with patch tests suggesting it is a frequent sensitizer among topical drugs.

This study found that a 2% topical minoxidil solution significantly increased hair regrowth compared to placebo in women with androgenetic alopecia over 32 weeks.

In this study on mice, a hydro-alcoholic solution containing kopexil significantly enhanced hair growth and increased hair-promoting factors without causing notable liver or kidney toxicity compared to minoxidil.

Recent Phase III trials reported that once daily 5% minoxidil foam significantly increased hair count in women with female pattern hair loss and was shown to be as effective as twice daily 2% minoxidil solution.

This article discusses the popularity of topical minoxidil and tretinoin for combating aging, but emphasizes that the cosmetic improvement of hair growth with minoxidil is more significant than statistical measures in androgenetic alopecia.

This study highlights the complex clinical issues associated with using low dose oral minoxidil for alopecia, emphasizing the need for careful cardiology-dermatology collaboration due to rare but serious cardiovascular risks, especially in patients with existing cardiorenal or cardiovascular concerns.

This article reviews the use of minoxidil for alopecia treatment and finds that low-dose oral or topical forms can be effective with manageable side effects, although some patients may still experience them.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

This report describes the case of identical twin males, where one applied topical 5% minoxidil for over a year on the beard and mustache area and the other did not, highlighting the anecdotal use of minoxidil for facial hair enhancement.

This study observed that low-dose oral minoxidil and topical minoxidil 5% solution both improved hair density in women with female-pattern hair loss, but oral minoxidil may offer advantages in reducing hair shedding.

This study found that hypertrichosis occurs in 23% of patients using minoxidil for alopecia, but only 0.49% discontinued treatment due to this side effect.

This abstract contains no research findings; it comprises website navigation and publication information.

This study evaluated a new aqueous-based nanosuspension of minoxidil for treating androgenetic alopecia and reported it was as effective as the commercial product but had better safety and tolerability, potentially improving patient compliance.

This systematic review and meta-analysis found that oral minoxidil may improve hair loss symptoms, with 35% of patients experiencing significant symptom improvement, but further research is needed to confirm its efficacy and safety, especially at doses exceeding 1 mg.

This study found that 5% minoxidil liniment was more effective than 2% minoxidil for treating female pattern hair loss over 6 months, with the higher dose showing significant improvement, especially in severe cases.